| 1 |
29207381 | Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis. | 2018 |
1 |
| 2 |
29757363 | Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1. | 2018 Aug 22 |
2 |
| 3 |
30137311 | Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. | 2018 Aug 22 |
1 |
| 4 |
29067882 | Alicaforsen in the treatment of pouchitis. | 2017 Nov |
1 |
| 5 |
26966529 | Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series. | 2016 Feb |
2 |
| 6 |
23473419 | Silver nanoscale antisense drug delivery system for photoactivated gene silencing. | 2013 Apr 23 |
2 |
| 7 |
23555914 | HIV Tat induces expression of ICAM-1 in HUVECs: implications for miR-221/-222 in HIV-associated cardiomyopathy. | 2013 |
1 |
| 8 |
22128256 | Lactosylceramide Mediates the Expression of Adhesion Molecules in TNF-α and IFNγ-stimulated Primary Cultured Astrocytes. | 2011 Oct |
1 |
| 9 |
20083573 | HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells. | 2010 Jul 15 |
1 |
| 10 |
17979170 | 2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA. | 2008 Jan |
1 |
| 11 |
18322230 | Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation. | 2008 Mar 15 |
1 |
| 12 |
16669955 | Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial. | 2006 May 15 |
1 |
| 13 |
16669956 | A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. | 2006 May 15 |
1 |
| 14 |
16764540 | Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302). | 2006 Summer |
1 |
| 15 |
16937430 | Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. | 2006 Aug 7 |
2 |
| 16 |
15489375 | VCAM-1 upregulation via PKCdelta-p38 kinase-linked cascade mediates the TNF-alpha-induced leukocyte adhesion and emigration in the lung airway epithelium. | 2005 Feb |
1 |
| 17 |
15591117 | Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation. | 2005 Apr 1 |
1 |
| 18 |
15790759 | Transcriptional regulation of inflammatory mediators secreted by human colonic circular smooth muscle cells. | 2005 Aug |
3 |
| 19 |
15860735 | Signal transducer and activator of transcription 3alpha and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium. | 2005 Jul |
1 |
| 20 |
16158332 | Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance. | 2005 Aug |
2 |
| 21 |
16197343 | Alicaforsen therapy in inflammatory bowel disease. | 2005 Oct |
2 |
| 22 |
14688373 | Intercellular adhesion molecule-1 mediates cellular cross-talk between parenchymal and immune cells after lipopolysaccharide neutralization. | 2004 Jan 1 |
1 |
| 23 |
14695770 | Cooperative inhibitory effects of antisense oligonucleotide of cell adhesion molecules and cimetidine on cancer cell adhesion. | 2004 Jan |
1 |
| 24 |
15063042 | On the biological activity of anti-ICAM-1 oligonucleotides complexed to non-viral carriers. | 2004 Apr 16 |
2 |
| 25 |
15480988 | TNFalpha suppresses human colonic circular smooth muscle cell contractility by SP1- and NF-kappaB-mediated induction of ICAM-1. | 2004 Oct |
1 |
| 26 |
15617021 | Effects of human and murine antisense oligonucleotide inhibitors of ICAM-1 on reproductive performance, fetal development, and post-natal development in mice. | 2004 Dec |
1 |
| 27 |
15617022 | Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbits. | 2004 Dec |
1 |
| 28 |
12826223 | Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides. | 2003 Jun |
2 |
| 29 |
14527564 | Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis. | 2003 Oct 15 |
1 |
| 30 |
12074367 | Antisense-mediated inhibition of ICAM-1 expression: a therapeutic strategy against inflammation of human periodontal tissue. | 2002 Apr |
1 |
| 31 |
12077088 | Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. | 2002 Jul |
2 |
| 32 |
12269969 | Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease. | 2002 Oct |
1 |
| 33 |
11181922 | Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats. | 2001 Mar |
1 |
| 34 |
11229813 | Sialyl Lewis(x)-liposomes as vehicles for site-directed, E-selectin-mediated drug transfer into activated endothelial cells. | 2001 Jan |
1 |
| 35 |
11233988 | Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase. | 2001 Feb |
1 |
| 36 |
11266874 | Development of an oral formulation for ICAM-1 antisense oligonucleotides. | 2001 Feb-Mar |
1 |
| 37 |
11267100 | Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. | 2001 Feb-Mar |
1 |
| 38 |
11313303 | Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease. | 2001 May |
1 |
| 39 |
11532196 | Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells. | 2001 |
3 |
| 40 |
11577588 | [Antibodies and immunomodulation]. | 2001 Sep 1 |
1 |
| 41 |
11750578 | Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. | 2001 Nov-Dec |
1 |
| 42 |
10623843 | Mechanism and function of a newly identified CpG DNA motif in human primary B cells. | 2000 Jan 15 |
1 |
| 43 |
10630964 | The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts. | 2000 Mar |
1 |
| 44 |
10706053 | Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2'-O-methoxyethyl antisense oligonucleotide. | 2000 Feb 15 |
7 |
| 45 |
11069617 | Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides. | 2000 Nov |
1 |
| 46 |
10037819 | Oligonucleotide-europium complex conjugate designed to cleave the 5' cap structure of the ICAM-1 transcript potentiates antisense activity in cells. | 1999 Mar 15 |
3 |
| 47 |
10378368 | [ICAM-1 antisense therapy: a new treatment concept on Crohn disease? Placebo controlled study of ICAM-1 antisense oligonucleotide therapy in Crohn disease]. | 1999 Apr |
1 |
| 48 |
10430938 | CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. | 1999 Aug 3 |
1 |
| 49 |
10438903 | Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells. | 1999 Aug 15 |
1 |
| 50 |
10453007 | Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA. | 1999 Sep 1 |
1 |